Summary
Renal and extrarenal effects of aldosterone antagonists on potassium balance were investigated in guinea pigs.
-
1.
Pretreatment with 2×120 μmoles/kg spironolactone orally for 3 days increased the tissue: plasma ratio of potassium in cardiac and skeletal muscle. Plasma potassium was unchanged.
-
2.
A single dose of 120 μmoles/kg spironolactone orally increased the urinary output of sodium. The renal excretion and clearance of potassium were unchanged.
-
3.
In the isolated heart, perfusion with spironolactone or canrenone induced an uptake of potassium. Canrenoate-K and aldosterone were inactive.
It is concluded that in guinea pigs aldosterone antagonists favour a shift of potassium from the extra- to the intracellular space by a direct effect on cardiac and skeletal muscle.
Similar content being viewed by others
References
Bauer, G., Rieckmann, P., Schaumann, W.: Einfluß von Teilchengröße und Lösungs-vermittlern auf die Resorption von Spironolacton aus dem Magen-Darmtrakt. Arzneimittel-Forsch. 12, 487–489 (1962)
Feller, D. R., Gerald, M. C.: Interactions of spironolactone with hepatic microsomal drug-metabolizing enzyme systems. Biochem. Pharmacol. 20, 1991–2000 (1971)
Gochmann, N., Gantt, C. L.: A fluorimetric method for the determination of a major spironolactone (Aldactone) metabolite in human plasma. J. Pharmacol. exp. Ther. 135, 312–316 (1962)
Hochrein, H., Reinert, M., Kriegsmann, B.: Der Extracellulärraum des Herz- und Skeletmuskels. Z. ges. exp. Med. 139, 79 (1965)
Lamarche, M., Royer, M.: Effet d'une spironolactone, le canrenoate de potassium, sur l'arythmie de l'oreillette isolee induite par un digitalique. C. R. Soc. Biol. (Paris) 165, 1432–1433 (1972)
Leber, H. W., Rawer, P., Schütterle, G.: Beeinflussung mikrosomaler Enzyme der Rattenleber durch Spironolacton, Etacrynsäure und Furosemid. Klin. Wschr. 49, 116 (1971)
McLennan, H.: The diffusion of potassium, inulin and thiocyanate in the extracellular spaces of mammalian muscle. Biochim. biophys. Acta (Amst.) 21, 472–481 (1956)
Schröder, R., Ramdohr, B., Hüttemann, U., Schüren, K. P.: Direkte positivinotrope Herzwirkung von Aldactone (Spironolacton, Canrenoat-Kalium). Dtsch. med. Wschr. 97, 1535–1538 (1972)
Selye, H.: Hormones and resistance. J. pharm. Sci. 60, 1–28 (1971)
Spach, C.: Dosage de l'inuline application a la mesure de l'espace inuline du rat et a celle du coeur de rat in vivo. Arch. Sci. physiol. 19, 359–368 (1965)
Yeh, B. K., Sung, P.-K., Saha, A. K.: Use of potassium canrenoate to suppress ouabain-induced ventricular arrhythmias in dogs. Circulat. Res. 31, 915–922 (1972)
Zicha, L., Weist, F., Scheiffarth, F., Schmid, E.: Dünnschichtchromatographische Untersuchungen des 3′-(3-Oxo-7α-acetylthio-17β-hydroxy-4-androsten-17-α-yl)-propinsäure-γ-lactons und seiner Metaboliten beim Menschen. Arzneimittel-Forsch. 14, 699–705 (1964)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mattern, H.R., Schaumann, W. Extrarenal effects of aldosterone antagonists in guinea pigs. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 1–8 (1973). https://doi.org/10.1007/BF00502062
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00502062